Collegium Pharmaceutical, Inc. (NASDAQ: COLL) is a Healthcare company (Drug Manufacturers - Specialty & Generic) with a market capitalization of $794M. The Maz Rating grades it against the other companies in its sector.
Collegium Pharmaceutical, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $25.55, Collegium Pharmaceutical, Inc. trades at 20.9x trailing earnings, 1.0x sales and 2.7x book value, with an EV/EBITDA of 4.5. Over the last twelve months it generated about $819M of revenue and $38M of net income. It runs a gross margin of 59.0%, an operating margin of 14.8% and a net margin of 4.7%. It shows return on equity of 12.5%, return on invested capital of 7.0% and a free cash flow yield of 42.4%. On the balance sheet: a debt-to-equity ratio of 3.67 and a current ratio of 1.01. Over the past 52 weeks the share price ranged from $21.43 to $50.79, with a beta of 0.73.
Collegium Pharmaceutical, Inc. does not currently pay a dividend.
12 Wall Street analyst ratings cover the stock: 8 Buy, 3 Hold and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.